{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:47:43Z","timestamp":1761155263996},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anaesth"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1007\/bf03011591","type":"journal-article","created":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T23:22:56Z","timestamp":1241220176000},"page":"845-849","source":"Crossref","is-referenced-by-count":28,"title":["Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?"],"prefix":"10.1007","volume":"41","author":[{"given":"Dermot","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin J.","family":"Brull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03011591_CR1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","volume":"142","author":"JL Levenson","year":"1985","unstructured":"Levenson, JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137\u201345.","journal-title":"Am J Psychiatry"},{"key":"BF03011591_CR2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00000542-198801000-00024","volume":"68","author":"J Geiduschek","year":"1988","unstructured":"Geiduschek J, Cohen SA, Khan A, Cullen BE Repeated anesthesia for a patient with neuroleptic malignant syndrome. Anesthesiology 1988; 68: 134\u20137.","journal-title":"Anesthesiology"},{"key":"BF03011591_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00000542-198707000-00004","volume":"67","author":"SN Caroff","year":"1987","unstructured":"Caroff SN, Rosenberg H, Fletcher JE, Heiman-Patterson TD, Mann SC. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. Anesthesiology 1987; 67: 20\u20135.","journal-title":"Anesthesiology"},{"key":"BF03011591_CR4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1176\/ajp.142.3.376","volume":"142","author":"BI Liskow","year":"1985","unstructured":"Liskow BI. Relationship between neuroleptic malignant syndrome and malignant hyperthermia (Letter). Am J Psychiatry 1985; 142: 390.","journal-title":"Am J Psychiatry"},{"key":"BF03011591_CR5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1213\/00000539-198309000-00014","volume":"62","author":"S Weinberg","year":"1983","unstructured":"Weinberg S, Twersky RS. Neuroleptic malignant syndrome. Anesth Analg 1983; 62: 848\u201350.","journal-title":"Anesth Analg"},{"key":"BF03011591_CR6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.4012304","volume":"228","author":"C Holden","year":"1985","unstructured":"Holden C. A guarded endorsement for shock therapy. Science 1985; 228: 1510\u20131.","journal-title":"Science"},{"key":"BF03011591_CR7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.143.10.1227","volume":"143","author":"HG Pope","year":"1986","unstructured":"Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986; 143: 1227\u201333.","journal-title":"Am J Psychiatry"},{"key":"BF03011591_CR8","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.1985.03360190101034","volume":"254","author":"R Sangal","year":"1985","unstructured":"Sangal R, Dimitrijevic R. Neuroleptic malignant syn- drome - successful treatment with pancuronium. JAMA 1985; 254: 2795\u20136.","journal-title":"JAMA"},{"key":"BF03011591_CR9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archinte.1984.00350150243048","volume":"144","author":"F Hashimoto","year":"1984","unstructured":"Hashimoto F, Sherman CB, Jeffery WH. Neuroleptic malignant syndrome and dopaminergic blockade. Arch Intern Med 1984; 144: 629\u201330.","journal-title":"Arch Intern Med"},{"key":"BF03011591_CR10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","volume":"31","author":"VW Henderson","year":"1981","unstructured":"Henderson VW, Wooten GF. Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade? Neurology 1981; 31: 132\u20137.","journal-title":"Neurology"},{"key":"BF03011591_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1213\/00000539-198304000-00007","volume":"62","author":"H Rosenberg","year":"1983","unstructured":"Rosenberg H, Reed S. In vitro contracture tests for susceptibility to malignant hyperthermia. Anesth Analg 1983; 62: 415\u201320.","journal-title":"Anesth Analg"},{"key":"BF03011591_CR12","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/bmj.288.6434.1878","volume":"288","author":"MA Denborough","year":"1984","unstructured":"Denborough MA, Collins SP, Hopkinson KC. Rhabdomyolysis and malignant hyperpyrexia. BMJ 1984; 288: 1878.","journal-title":"BMJ"},{"key":"BF03011591_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.38.2.297","volume":"38","author":"M Araki","year":"1988","unstructured":"Araki M, Takagi A, Higuchi I, Sugita H. Neuroleptic malignant syndrome: caffeine contracture of single muscle fibers and muscle pathology. Neurology 1988; 38: 297\u2013301.","journal-title":"Neurology"},{"key":"BF03011591_CR14","first-page":"266","volume":"2","author":"G Tollefson","year":"1982","unstructured":"Tollefson G. A case of neuroleptic malignant syndrome:in vitro muscle comparison with malignant hyperthermia. J Clin Psychopharmacol 1982; 2: 266\u201370.","journal-title":"J Clin Psychopharmacol"},{"key":"BF03011591_CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1445-5994.1983.tb04554.x","volume":"13","author":"JD Scarlett","year":"1983","unstructured":"Scarlett JD, Zimmerman R, Berkovic SF Neuroleptic malignant syndrome. Aust N Z J Med 1983; 13: 70\u20133.","journal-title":"Aust N Z J Med"},{"key":"BF03011591_CR16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.7326\/0003-4819-106-1-172_1","volume":"106","author":"AL George","year":"1987","unstructured":"George AL Jr, Wood CA Jr. Succinylcholine-induced hyperkalemia complicating the neuroleptic malignant syndrome (Letter). Ann Intern Med 1987; 106: 172.","journal-title":"Ann Intern Med"},{"key":"BF03011591_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00000542-198805000-00010","volume":"68","author":"JJ Savarese","year":"1988","unstructured":"Savarese JJ, Ali H H, Basta SJ, et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723\u201332.","journal-title":"Anesthesiology"},{"key":"BF03011591_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1213\/00000539-199009000-00012","volume":"71","author":"RL Sufit","year":"1990","unstructured":"Sufit RL, Kreul JF, Bellay YM, Helmer P, Brunson DB, Will J. Doxacurium and mivacurium do not trigger malignant hyperthermia in susceptible swine. Anesth Analg 1990; 71: 285\u20137.","journal-title":"Anesth Analg"},{"key":"BF03011591_CR19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/bja\/61.5.541","volume":"61","author":"HH Ali","year":"1988","unstructured":"Ali HH, Savarese JJ, Embree PB, et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. Br J Anaesth 1988; 61: 541\u20136.","journal-title":"Br J Anaesth"},{"key":"BF03011591_CR20","first-page":"2061","volume-title":"Anesthesia","author":"JM Messick","year":"1990","unstructured":"Messick JM Jr, MacKenzie RA, Nugent M. Anesthesia at remote locations.In: Miller RD (Ed.). Anesthesia, 3rd ed. New York: Churchill Livingstone, 1990: 2061\u201388.","edition":"3rd ed."},{"key":"BF03011591_CR21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00000542-198903000-00003","volume":"70","author":"JJ Savarese","year":"1989","unstructured":"Savarese JJ, Ali HH, Basta SJ, et al. The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology 1989; 70: 386\u201394.","journal-title":"Anesthesiology"}],"container-title":["Canadian Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03011591.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03011591\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03011591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T18:48:59Z","timestamp":1558464539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03011591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["BF03011591"],"URL":"https:\/\/doi.org\/10.1007\/bf03011591","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}